Inovio Pharmaceuticals Inc. closed $12.79 short of its 52-week high ($14.75), which the company achieved on April 1st.

Inovio Pharmaceuticals Inc. closed $12.93 below its 52-week high ($14.75), which the company achieved on April 1st.

Inovalis REIT is an intriguing speculative opportunity. It's had a horrible past few years of performance and is now a penny ...

The company priced a public offering of 10 million shares of common stock and accompanying warrants. Discover Fast-Growing Stocks Every Month Inovio Pharmaceuticals Inc INO shares are trading ...

State Street Corp raised its position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) by 11.7% in the third quarter, Holdings Channel.com reports. The institutional investor owned 490,662 ...

Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In terms of launching INO-3107, Shea and others chose their words ... the title comes from the prospect of potential gain if the stock recovers or snaps back. I do not expect Inovio to experience ...

Inovio (INO) Pharmaceuticals announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of its common stock, in an underwritten public ...

View Inovio option chain data and compare options for INO stock. Gain insights into the options market sentiment and the potential trading activity surrounding Inovio stock. View the call options (the ...